Search

Home > New FDA Approvals > 072 - JAK2 Assay for MPNs; Generic Estrace® Cream and Epiduo® Gel; Traumakine for ARDS; NanoKnife® for pancreatic cancer; VY-AADC for Parkinson’s; CAB-AXL-ADC Therapeutic; FDA warns about unapproved opioid cessation products; CRISP human studies in
Podcast: New FDA Approvals
Episode:

072 - JAK2 Assay for MPNs; Generic Estrace® Cream and Epiduo® Gel; Traumakine for ARDS; NanoKnife® for pancreatic cancer; VY-AADC for Parkinson’s; CAB-AXL-ADC Therapeutic; FDA warns about unapproved opioid cessation products; CRISP human studies in

Category: Science & Medicine
Duration: 00:14:41
Publish Date: 2018-01-25 07:00:00
Description:

 

January 25, 2018

0:47 FDA approves first JAK2 Assay for MPNs https://www.journalofclinicalpathways.com/news/fda-approves-first-jak2-assay-mpns

2:24 Approval of Generic Estrace® Cream and Epiduo® Gel

https://www.prnewswire.com/news-releases/perrigo-announces-final-fda-approval-of-a-generic-version-of-estrace-cream-300587431.html

https://www.prnewswire.com/news-releases/perrigo-announces-final-fda-approval-and-launch-of-an-ab-rated-generic-version-of-epiduo-gel-300587429.html

3:21 IND for Traumakine http://www.raredr.com/news/fda-approves-traumakine-ind

4:29 NanoKnife® system for the treatment of stage III pancreatic cancer http://investors.angiodynamics.com/releasedetail.cfm?ReleaseID=1055166

5:40 IND for VY-AADC for Advanced Parkinson’s Disease http://ir.voyagertherapeutics.com/phoenix.zhtml?c=254026&p=irol-newsArticle&ID=2327863

8:18 IND for CAB-AXL-ADC Therapeutic https://www.prnewswire.com/news-releases/bioatla-announces-fda-clearance-of-investigational-new-drug-application-for-cab-axl-adc-therapeutic-300587259.html

9:54 FDA, FTC warn companies for selling illegal, unapproved opioid cessation products using deceptive claims https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm593602.htm

11:30 Chinese scientists used Crispr gene editing on 86 human patients https://qz.com/1185488/chinese-scientists-used-crispr-gene-editing-on-86-human-patients/

Nascent Medical info@nascentmc.com

Total Play: 0